Inventor

BOURDOULOUS SANDRINE

FR5 patents

⚠️ This page may combine multiple inventors who share the name “BOURDOULOUS SANDRINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV PARIS

1 patent

US11352627B2Jun 7, 2022

Treatment of HER-2 dependent cancer using an agent that modulates the activity of a miRNA

UNIV PARIS0 citations49

UNIV PARIS CITE

1 patent

US11814685B2Nov 14, 2023

Diagnosis and/or prognosis of HER2-dependent cancer using one or more miRNA as a biomarker

UNIV PARIS CITE0 citations47

INST NAT SANTE RECH MED

1 patent

US10000545B2Jun 19, 2018

CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endothelia

INST NAT SANTE RECH MED1 citations43

CENTRE NAT RECH SCIENT

1 patent

US10766873B2Sep 8, 2020

Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors

CENTRE NAT RECH SCIENT0 citations31

BOURDOULOUS SANDRINE

1 patent

US9127077B2Sep 8, 2015

Polypeptides and nucleic acids for treating ErbB2-dependent cancers

BOURDOULOUS SANDRINE0 citations31